APA (7th ed.) Citation

T, D., WJ, J., RB, P., PM, C., MM, R., TJ, B., . . . ZS, M. (2026). In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models. Cancer immunology research. https://doi.org/10.1158/2326-6066.CIR-25-1475

Chicago Style (17th ed.) Citation

T, Debnath, et al. "In Situ Vaccination, Low-dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models." Cancer Immunology Research 2026. https://doi.org/10.1158/2326-6066.CIR-25-1475.

MLA (9th ed.) Citation

T, Debnath, et al. "In Situ Vaccination, Low-dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models." Cancer Immunology Research, 2026, https://doi.org/10.1158/2326-6066.CIR-25-1475.